| 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data-driven methodology … CH Shiboski, SC Shiboski, R Seror, LA Criswell, M Labetoulle, ... Annals of the rheumatic diseases 76 (1), 9-16, 2017 | 2542 | 2017 |
| Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis N Wegner, K Lundberg, A Kinloch, B Fisher, V Malmström, M Feldmann, ... Immunological reviews 233 (1), 34-54, 2010 | 640 | 2010 |
| EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies M Ramos-Casals, P Brito-Zerón, S Bombardieri, H Bootsma, S De Vita, ... Annals of the rheumatic diseases 79 (1), 3-18, 2020 | 521 | 2020 |
| Antibodies to citrullinated α‐enolase peptide 1 are specific for rheumatoid arthritis and cross‐react with bacterial enolase K Lundberg, A Kinloch, BA Fisher, N Wegner, R Wait, P Charles, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 517 | 2008 |
| Specific interaction between genotype, smoking and autoimmunity to citrullinated α-enolase in the etiology of rheumatoid arthritis H Mahdi, BA Fisher, H Källberg, D Plant, V Malmström, J Rönnelid, ... Nature genetics 41 (12), 1319-1324, 2009 | 409 | 2009 |
| Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid … AM Quirke, EB Lugli, N Wegner, BC Hamilton, P Charles, M Chowdhury, ... Annals of the rheumatic diseases 73 (1), 263-269, 2014 | 270 | 2014 |
| Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome BA Fisher, R Jonsson, T Daniels, M Bombardieri, RM Brown, P Morgan, ... Annals of the rheumatic diseases 76 (7), 1161-1168, 2017 | 269 | 2017 |
| IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs F Barone, S Nayar, J Campos, T Cloake, DR Withers, KM Toellner, ... Proceedings of the National Academy of Sciences 112 (35), 11024-11029, 2015 | 218 | 2015 |
| Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis M Juarez, H Bang, F Hammar, U Reimer, B Dyke, I Sahbudin, CD Buckley, ... Annals of the rheumatic diseases 75 (6), 1099-1107, 2016 | 199 | 2016 |
| Metabolic profiling predicts response to anti–tumor necrosis factor α therapy in patients with rheumatoid arthritis SR Kapoor, A Filer, MA Fitzpatrick, BA Fisher, PC Taylor, CD Buckley, ... Arthritis & Rheumatism 65 (6), 1448-1456, 2013 | 159 | 2013 |
| Cardiovascular complications induced by cannabis smoking: a case report and review of the literature BAC Fisher, A Ghuran, V Vadamalai, TF Antonios Emergency medicine journal 22 (9), 679-680, 2005 | 152 | 2005 |
| The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome EJ Price, S Rauz, AR Tappuni, N Sutcliffe, KL Hackett, F Barone, ... Rheumatology 56 (10), e24-e48, 2017 | 147 | 2017 |
| Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of … A Labirua-Iturburu, A Selva-O’Callaghan, M Vincze, K Dankó, ... Medicine 91 (4), 206-211, 2012 | 144 | 2012 |
| Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology S Nayar, J Campos, CG Smith, V Iannizzotto, DH Gardner, F Mourcin, ... Proceedings of the National Academy of Sciences 116 (27), 13490-13497, 2019 | 143 | 2019 |
| Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren’s syndrome with ectopic germinal centres and MALT lymphoma E Pontarini, WJ Murray-Brown, C Croia, D Lucchesi, J Conway, ... Annals of the rheumatic diseases 79 (12), 1588-1599, 2020 | 130 | 2020 |
| Guidelines for biomarkers in autoimmune rheumatic diseases-evidence based analysis R Giacomelli, A Afeltra, A Alunno, E Bartoloni-Bocci, O Berardicurti, ... Autoimmunity reviews 18 (1), 93-106, 2019 | 130 | 2019 |
| Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial SJ Bowman, R Fox, T Dörner, X Mariette, A Papas, T Grader-Beck, ... The Lancet 399 (10320), 161-171, 2022 | 129 | 2022 |
| Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases I Korsunsky, K Wei, M Pohin, EY Kim, F Barone, T Major, E Taylor, ... Med 3 (7), 481-518. e14, 2022 | 128 | 2022 |
| Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study BA Fisher, A Szanto, WF Ng, M Bombardieri, MG Posch, AS Papas, ... The Lancet Rheumatology 2 (3), e142-e152, 2020 | 122 | 2020 |
| Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy BA Fisher, CC Everett, J Rout, JL O’Dwyer, P Emery, C Pitzalis, WF Ng, ... Annals of the rheumatic diseases 77 (3), 412-416, 2018 | 119 | 2018 |
